Sign in

CIK 0001840233 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Xilio Therapeutics, Inc.

Sign in to watch
Ticker
XLO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851623397
Phone
617-833-1027
Business address
828 WINTER STREET, WALTHAM, MA, 02451
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. CERT Other Certification
  5. S-1/A Offering Registration Statement
  6. CORRESP Other Correspondence Between Filers and SEC Staff
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. 8-A12B Other Registration of Securities
  9. CORRESP Other Correspondence Between Filers and SEC Staff
  10. S-1/A Offering Registration Statement
  11. UPLOAD Other SEC-generated Letter
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. S-1 Offering Registration Statement
  14. UPLOAD Other SEC-generated Letter
  15. DRSLTR Other Correspondence Related to Draft Registration Statement
  16. DRS/A Other Draft Registration Statement
  17. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  18. UPLOAD Other SEC-generated Letter
  19. DRS Other Draft Registration Statement
  20. D Other Notice of Sales of Unregistered Securities

Page 18 of 19 · 361 filings